Re: Reports of Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jonzobot

Rank: President [?]

Points: 2527 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Reports of Exempt Distribution

in response to

Re: Reports of Exempt Distribution

KOO-KOO2

posted on Feb 23, 2023 02:56PM

These financings seem to be getting cheaper and cheaper.

Wasn't it $1.50 a while ago, and $2 before that?

Going in the wrong direction...

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply